Brett J. Prigaro

1.5k total citations · 1 hit paper
7 papers, 1.1k citations indexed

About

Brett J. Prigaro is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Brett J. Prigaro has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Brett J. Prigaro's work include Hepatitis C virus research (3 papers), Biochemical and Molecular Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Brett J. Prigaro is often cited by papers focused on Hepatitis C virus research (3 papers), Biochemical and Molecular Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). Brett J. Prigaro collaborates with scholars based in United States and Denmark. Brett J. Prigaro's co-authors include Sanjay Bhanot, Varman T. Samuel, Demetrios T. Braddock, João Paulo Camporez, Derek M. Erion, Anila K. Madiraju, Xian‐Man Zhang, Richard G. Kibbey, Ronald A. Albright and Michael J. Jurczak and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Brett J. Prigaro

7 papers receiving 1.1k citations

Hit Papers

Metformin suppresses gluc... 2014 2026 2018 2022 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett J. Prigaro United States 6 828 334 303 204 125 7 1.1k
Keisuke Shioji Japan 24 590 0.7× 295 0.9× 154 0.5× 157 0.8× 58 0.5× 55 1.5k
Jennifer Pattison United States 16 793 1.0× 645 1.9× 155 0.5× 245 1.2× 221 1.8× 18 1.8k
Sung-Hee Ihm South Korea 19 362 0.4× 247 0.7× 314 1.0× 96 0.5× 80 0.6× 61 1.0k
Marcos L. Sznaidman United States 9 1.1k 1.3× 242 0.7× 99 0.3× 402 2.0× 161 1.3× 25 1.3k
Takashi Obama Japan 21 429 0.5× 191 0.6× 93 0.3× 137 0.7× 84 0.7× 43 1.1k
Steven S. Mundt United States 15 375 0.5× 398 1.2× 432 1.4× 173 0.8× 119 1.0× 23 1.4k
Kesong Peng China 21 730 0.9× 192 0.6× 94 0.3× 84 0.4× 180 1.4× 28 1.3k
Megan Settle United States 11 520 0.6× 659 2.0× 443 1.5× 336 1.6× 177 1.4× 11 1.7k
Edward E. Cable United States 23 602 0.7× 170 0.5× 362 1.2× 106 0.5× 55 0.4× 40 1.4k

Countries citing papers authored by Brett J. Prigaro

Since Specialization
Citations

This map shows the geographic impact of Brett J. Prigaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett J. Prigaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett J. Prigaro more than expected).

Fields of papers citing papers by Brett J. Prigaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett J. Prigaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett J. Prigaro. The network helps show where Brett J. Prigaro may publish in the future.

Co-authorship network of co-authors of Brett J. Prigaro

This figure shows the co-authorship network connecting the top 25 collaborators of Brett J. Prigaro. A scholar is included among the top collaborators of Brett J. Prigaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett J. Prigaro. Brett J. Prigaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ren, Li, David Moreno‐Mateos, Brian R. Baer, et al.. (2024). Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 67(15). 13019–13032. 1 indexed citations
2.
Prigaro, Brett J., Hector Esquer, Qiong Zhou, et al.. (2022). Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. Journal of Medicinal Chemistry. 65(5). 3943–3961. 11 indexed citations
3.
Madiraju, Anila K., Derek M. Erion, Yasmeen Rahimi, et al.. (2014). Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 510(7506). 542–546. 961 indexed citations breakdown →
4.
Lagisetti, Chandraiah, et al.. (2013). Pre-mRNA Splicing-Modulatory Pharmacophores: The Total Synthesis of Herboxidiene, a Pladienolide–Herboxidiene Hybrid Analog and Related Derivatives. ACS Chemical Biology. 9(3). 643–648. 56 indexed citations
5.
Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2005). Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase. Bioorganic Chemistry. 34(1). 26–38. 49 indexed citations
6.
Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2004). Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 15(3). 675–678. 28 indexed citations
7.
Smith, Kenneth L., Vicky C. H. Lai, Brett J. Prigaro, et al.. (2004). Synthesis of new 2′-β-C-methyl related triciribine analogues as anti-HCV agents. Bioorganic & Medicinal Chemistry Letters. 14(13). 3517–3520. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026